Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGastroenterology Physician in Cleveland, OH
NPI: 1114142791Primary Practice Location
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH
Primary Employer
Cleveland Clinic
clevelandclinic.org
HQ Phone
Get M.D. Scott's Phone Numberphone_androidMobile
Get M.D. Scott's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
NH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 114 | 141 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 84 | 84 |
| 3 | 91010Measurement of esophageal swallowing movement | 76 | 77 |
| 4 | G0500Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 72 | 87 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 67 | 76 |
The case of self-resolving type III achalasia after bilateral lung transplant.
Manometric Esophageal Length to Height (MELH) Ratio Predicts Hiatal Hernia Recurrence.
Authors: Siva Raja, Monica Ray, Andrew Tang, Sudish Murthy, Prashanthi Thota
Journal: J Clin Gastroenterol
Lead Sponsor: Shire
Intervention / Treatment: DRUG: Placebo, DRUG: Oral Budesonide Suspension (OBS)
Lead Sponsor: Shire
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: DRUG: Budesonide oral suspension
Lead Sponsor: Shire
Intervention / Treatment: DRUG: Placebo, DRUG: Oral Budesonide Suspension (OBS)
